KIORA PHARMACEUTICALS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate
KIORA PHARMACEUTICALS, INC. (KPRX) reported Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate of 4.12% for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate · last filed 2026-08-07
- KIORA PHARMACEUTICALS, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for the quarter ending 2026-03-31 was 3.83%.
- KIORA PHARMACEUTICALS, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for the quarter ending 2023-03-31 was 4.26%, a 76.03% increase year-over-year.
- KIORA PHARMACEUTICALS, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for the quarter ending 2022-03-31 was 2.42%, a 32.97% increase year-over-year.
- KIORA PHARMACEUTICALS, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for the quarter ending 2021-03-31 was 1.82%, a 0.00% change year-over-year.
- KIORA PHARMACEUTICALS, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for fiscal 2022 was 2.42%, a 32.97% increase from fiscal 2021.
- KIORA PHARMACEUTICALS, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for fiscal 2021 was 1.82%, a 0.00% change from fiscal 2020.
- KIORA PHARMACEUTICALS, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for fiscal 2020 was 1.82%, a 0.00% change from fiscal 2019.
- KIORA PHARMACEUTICALS, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for fiscal 2019 was 1.82%, a 0.00% change from fiscal 2018.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate 6 month as first filed | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | 4.12% 10-Q · filed 2026-08-07 | ||||
| 2026-03-31 | 3.83% 10-Q · filed 2026-05-08 | ||||
| 2025-09-30 | 3.97% 10-Q · filed 2025-11-07 | ||||
| 2025-06-30 | 3.97% 10-Q · filed 2026-08-07 | ||||
| 2024-09-30 | 4.44% 10-Q · filed 2025-11-07 | ||||
| 2023-09-30 | 4.54% 10-Q · filed 2024-11-08 | ||||
| 2023-06-30 | 4.26% 10-Q · filed 2024-08-09 | 4.24% 10-Q · filed 2023-08-08 | |||
| 2023-03-31 | 4.26% 10-Q · filed 2024-05-10 | ||||
| 2022-12-31 | 2.42% 10-K · filed 2024-03-25 | ||||
| 2022-09-30 | 2.42% 10-Q · filed 2023-11-09 | ||||
| 2022-06-30 | 2.42% 10-Q · filed 2023-08-08 | ||||
| 2022-03-31 | 2.42% 10-Q · filed 2023-05-09 | ||||
| 2021-12-31 | 1.82% 10-K · filed 2023-03-23 | ||||
| 2021-09-30 | 1.82% 10-Q · filed 2022-11-09 | ||||
| 2021-06-30 | 1.82% 10-Q · filed 2022-08-12 | ||||
| 2021-03-31 | 1.82% 10-Q · filed 2021-05-12 | ||||
| 2020-12-31 | 1.82% 10-K/A · filed 2022-07-07 | ||||
| 2020-09-30 | 1.82% 10-Q · filed 2021-11-15 | ||||
| 2020-06-30 | 1.82% 10-Q · filed 2021-08-12 | ||||
| 2020-03-31 | 1.82% 10-Q · filed 2021-05-12 | ||||
| 2019-12-31 | 1.82% 10-K · filed 2021-03-25 | ||||
| 2019-09-30 | 1.82% 10-Q · filed 2020-11-09 | ||||
| 2019-06-30 | 1.82% 10-Q · filed 2020-08-06 | ||||
| 2019-03-31 | 1.82% 10-Q · filed 2020-05-06 | ||||
| 2018-12-31 | 1.82% 10-K · filed 2020-03-04 | ||||
| 2018-09-30 | 1.82% 10-Q · filed 2019-11-07 | ||||
| 2018-06-30 | 1.82% 10-Q · filed 2019-08-08 | ||||
| 2018-03-31 | 1.82% 10-Q · filed 2019-05-08 | ||||
| 2017-12-31 | 1.82% 10-K · filed 2019-03-01 | ||||
| 2017-09-30 | 1.82% 10-Q · filed 2018-11-13 | ||||
| 2017-06-30 | 1.82% 10-Q · filed 2018-08-03 | ||||
| 2017-03-31 | 1.82% 10-Q · filed 2018-05-11 | ||||
| 2016-12-31 | 1.82% 10-K · filed 2018-03-02 | ||||
| 2016-09-30 | 1.82% 10-Q · filed 2017-11-14 | ||||
| 2016-06-30 | 1.82% 10-Q · filed 2017-08-04 | ||||
| 2016-03-31 | 1.82% 10-Q · filed 2017-05-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |